Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Bowers v. Tesaro Inc. et al
Case Number:
1:18-cv-10086
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Andrews DeValerio
- Hogan Lovells
- Hutchings Barsamian
- Kessler Topaz
- Matorin Law Office
- Murphy Anderson PLLC
- Pomerantz LLP
- Shapiro Haber
Companies
Sectors & Industries:
-
May 04, 2018
Kessler Topaz Wins Lead In Cancer Drug Stock-Drop Suit
Kessler Topaz Meltzer & Check LLP and its investor client on Friday secured the roles of lead counsel and plaintiff in a proposed securities class action against Tesaro Inc. blaming the pharmaceutical company for stock losses after regulators issued a national safety alert on its antiemetic cancer drug.
-
March 20, 2018
Firms Clamor To Lead Cancer Drug Stock-Drop Suit In Boston
Robbins Geller Rudman & Dowd LLP, Pomerantz LLP and several other law firms have jumped at the opportunity to lead a proposed securities class action in Massachusetts federal court against Tesaro Inc. in the wake of a national safety alert issued on its anti-nausea drug for cancer patients.